Treace Medical Concepts, Inc.
TMCI
$7.47
-$0.23-2.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.96% | 14.75% | 92.02% | 12.33% | -72.81% |
| Total Depreciation and Amortization | 21.74% | 28.92% | -2.52% | 37.92% | 93.24% |
| Total Amortization of Deferred Charges | 0.00% | -1.33% | 87.28% | -1.33% | 0.00% |
| Total Other Non-Cash Items | 12.21% | 24.85% | 69.50% | 30.40% | 131.12% |
| Change in Net Operating Assets | 137.46% | 394.80% | -1,022.16% | -868.25% | -240.29% |
| Cash from Operations | 78.05% | 158.14% | -890.79% | -24.48% | -66.73% |
| Capital Expenditure | -175.71% | 9.78% | -36.74% | 18.22% | 59.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.75% | -78.54% | -10.48% | 6.52% | 74.99% |
| Cash from Investing | -114.52% | -150.40% | -31.68% | 25.36% | 315.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -62.70% | 128.85% | -67.98% | -99.90% | -- |
| Repurchase of Common Stock | -- | -69.20% | -138.46% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 217.36% | -52.43% | -84.24% | -94.97% | -73.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.13% | 155.43% | -113.32% | -27.62% | 150.33% |